Estrogen induction of hepatocellular carcinomas in Armenian hamsters
Corresponding Author
John E. Coe M.D
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840
National Institutes of Health, NIAID, Lab of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840===Search for more papers by this authorKamal G. Ishak
Armed Forces Institute of Pathology, Washington, District of Columbia 20306-6000
Search for more papers by this authorMary Jane Ross
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840
Search for more papers by this authorCorresponding Author
John E. Coe M.D
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840
National Institutes of Health, NIAID, Lab of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840===Search for more papers by this authorKamal G. Ishak
Armed Forces Institute of Pathology, Washington, District of Columbia 20306-6000
Search for more papers by this authorMary Jane Ross
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840
Search for more papers by this authorAbstract
Liver tumors were found in most Armenian hamsters (Cricetulus migratorius) injected with on 15-mg pellet of diethylstilbestrol. The tumors were detectable as early as 1.5 mo after diethylstilbestrol administration and were usually present as multiple nodules that progressively increased in size. Histologically, the multicentric neoplasms were all hepatocellular carcinomas of varied degrees of differentiation and frequently (42.8%) contained Mallory bodies; preneoplastic lesions were not observed. This hepatocellular carcinoma hamster model is unique because estrogen alone without any other known mutagen is responsible for induction of hepatocellular carcinoma.(HEPATOLOGY 1990; 11:570:577.)
References
- 1 Herbst AL, Ultelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 248: 878–881.
- 2 Endo H, Murakami T, Nishimoto I, Sekine I, Yokoyama M. Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer. Acta Pathol Jpn 1987; 37: 795–806.
- 3 Hoch-Ligeti C. Angiosarcoma of the liver associated with diethystilbestrol. JAMA 1978; 240: 1510–1511.
- 4 Baum JK, Holtz F, Bookstein JJ, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926–929.
- 5 Mahboubi E, Shubik P. Benign liver cell adenomas in women using oral contraceptives. Cancer Lett 1976; 1: 331–338.
- 6 Mays ET, Christopherson WM. Hepatic tumors induced by sex steroids. Semin Liver Dis 1984; 4: 147–157.
- 7 Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Paganini A, Tyler CW. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979; 242: 644–648.
- 8 Edmondson HA, Henderson B, Benton B. Liver cell adenomas: association with use of oral contraceptives. N Engl J Med 1976; 294: 470–472.
- 9 Neuberger J, Forman D, Doll R, Williams R. Oral contraceptives and hepatocellular carcinoma. Br Med J [Clin Res] 1986; 292: 1355–1357.
- 10 Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J [Clin Res] 1986; 292: 1357–1361.
- 11 Henderson BS, Preston-Martin S, Edmondson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983; 48: 437–440.
- 12 Goodman ZD, Ishak KG. Hepatocellular carcinoma in women: a possible lack of etiologic association with oral contraceptive steroids. HEPATOLOGY 1982; 2: 440–444.
- 13 Estrogens in the environment. II. Influences on development. In: JA McLachlan, ed. Proceedings of the symposium, estrogens in the environment. New York: Elsevier, 1985.
- 14 Hertz R. A review of the evidence linking estrogens and cancer in animals. Pediatrics 1978; 62: 1138–1142.
- 15 Porter LE, Van Thiel DH, Eagon PK. Estrogens and progestins as tumor inducers. Semin Liver Dis 1987; 7: 24–31.
- 16 Yager JD, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 1980; 40: 3680–3685.
- 17 Wanless IR, Medline A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest 1982; 46: 313–320.
- 18 Coe JE, Ishak KG, Ross MJ. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. HEPATOLOGY 1983; 3: 489–496.
- 19 Coe JE, Ross MJ. Tamoxifen inhibits estrogen-induced hepatic injury in hamsters. Endocrinology 1988; 122: 137–144.
- 20 Coe JE, Ross MJ. Hamster female protein, a pentameric oligomer capable of reassociation and hybrid formation. Biochemistry 1987; 26: 704–710.
- 21 Luna LG. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3rd ed. New York: McGraw-Hill, 1968.
- 22 Frith CH, Ward JM. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J Environ Pathol Toxicol Oncol 1980; 3: 329–351.
- 23 Kirkman H, Bacon RL. Estrogen-induced tumors of the kidney. II. Effect of dose, administration, type of estrogen and age on the induction of renal tumors in intact male golden hamsters. J Natl Cancer Inst 1952; 13: 757–771.
- 24 Reznik-Schuller H. Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. J Natl Cancer Inst 1979; 62: 1083–1088.
- 25 Bannasch P. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 1986; 7: 689–695.
- 26 Ward JM. Morphology of potential preneoplastic hepatocyte lesions and liver tumors in In: JA Popp, ed. Mouse hepatic neoplasia. Washington, DC: Hemisphere, 1984; 1–26.
- 27 Nakanuma Y, Ohta G. Small hepatocellular carcinoma containing many Mallory bodies, Liver 1984; 4: 128–133.
- 28
Nakanuma Y,
Ohta G.
Expression of Mallory bodies in hepatocellular carcinoma in man and its significance.
Cancer
1986;
57:
81–86.
10.1002/1097-0142(19860101)57:1<81::AID-CNCR2820570117>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar
- 29 French SW. Mallory bodies in hepatic neoplasms: What does it mean? HEPATOLOGY 1986; 6: 1428–1430.
- 30
Nakoshima T,
Kojiro M.
Hepatocellular carcinoma: an atlas of its pathology.
Tokyo: Springer-Verlag,
1987;
43.
10.1007/978-4-431-68334-6 Google Scholar
- 31 Metzler M. Biochemical Toxicology of diethylstillbestrol. In: E Hodgson, JR Bend, RM Philpot eds. Reviews in Biochemical Toxicology. Vol. 6. New York: Elsevier Science Publishing Co., 1984; 191–220.
- 32 Li JJ, Li SA. High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed alpha-naphthoflavone: a new tumor model. J Natl Cancer Inst 1984; 73: 543–547.
- 33 Blaich G, Metzler M. Effect of pretreatment of male Syrian golden hamsters with 7, 8-benzoflavone and with diethylstilbestrol on P-450 isoenzyme activities and on microsomal diethyltilbestrol metabolism. J Steroid Biochem 1988; 31: 971–978.
- 34 Coe JE. Homologs of CRP: a diverse family of proteins with similar structure. In: FP Inman, TJ Kindt, eds. Contemporary topics in molecular immunology. Vol. 9. New York/London: Plenum Publishing Corp., 1983: 211–238.
- 35 Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to V-erb-A. Nature 1986; 320: 134–139.
- 36 Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150–1154.
- 37 Dejean A, Bougvelert L, Grzeschik K-H, Tiollais P. Hepatitic B virus DNA integration in a sequence homologus to V-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 1986; 322: 70–72.
- 38 Edwards DP, Chamness GC, McGuire WL. Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta 1979; 560: 457–486.